Cargando…

MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma

Glioblastoma multiforme (GBM) is a chemotherapy-resistant brain tumor with limited treatment options. Temozolomide (TMZ), an alkylating agent, is a front-line chemotherapeutic drug currently employed in GBM. Although it is currently the most promising chemotherapy for GBM, resistance to TMZ is also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Tian, Mingyi, Ma, Qiu, Xia, Qiu, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346737/ https://www.ncbi.nlm.nih.gov/pubmed/27792996 http://dx.doi.org/10.18632/oncotarget.12861

Ejemplares similares

Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA‐101 in glioblastoma
por: Cai, Tao, et al.
Publicado: (2018)

TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT
por: Nie, Er, et al.
Publicado: (2020)

MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9
por: Liu, Nan, et al.
Publicado: (2016)

Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma
por: Kitabayashi, Tomohiro, et al.
Publicado: (2019)

MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype
por: Yan, Wei, et al.
Publicado: (2015)

Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway
por: Peng, Yujiang, et al.
Publicado: (2018)

LncRNA Rik-203 contributes to anesthesia neurotoxicity via microRNA-101a-3p and GSK-3β-mediated neural differentiation
por: Zhang, Lei, et al.
Publicado: (2019)

MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells
por: Wang, Hongqin, et al.
Publicado: (2019)

MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT
por: Zhao, Chengbin, et al.
Publicado: (2020)

MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway
por: Sun, Jiling, et al.
Publicado: (2015)

MicroRNA-30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin 1 and inhibiting autophagy
por: Xu, Jing, et al.
Publicado: (2018)

Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D
por: Munoz, Jessian L., et al.
Publicado: (2019)

Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets
por: Zheng, Fang, et al.
Publicado: (2015)

Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment
por: Adamski, Vivian, et al.
Publicado: (2017)

Celecoxib reverses the glioblastoma chemo-resistance to temozolomide through mitochondrial metabolism
por: Yin, Delong, et al.
Publicado: (2021)

GSK3β palmitoylation mediated by ZDHHC4 promotes tumorigenicity of glioblastoma stem cells in temozolomide-resistant glioblastoma through the EZH2–STAT3 axis
por: Zhao, Chenggang, et al.
Publicado: (2022)

Novel MicroRNA Reporter Uncovers Repression of Let-7 by GSK-3β
por: Guo, Rong, et al.
Publicado: (2013)

MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1
por: Jiang, Chunming, et al.
Publicado: (2016)

MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers
por: Liu, Hai-Ting, et al.
Publicado: (2015)

Correction: Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets
por: Zheng, Fang, et al.
Publicado: (2021)

MicroRNA-101a regulates microglial morphology and inflammation
por: Saika, Reiko, et al.
Publicado: (2017)

MicroRNA in Glioblastoma: An Overview
por: Banelli, Barbara, et al.
Publicado: (2017)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy
por: Gan, Jing, et al.
Publicado: (2016)

MicroRNA-101 inhibits renal tubular epithelial-to-mesenchymal transition by targeting TGF-β1 type I receptor
por: Wang, Qinglan, et al.
Publicado: (2021)

MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma
por: Cheng, Zhen-Xiu, et al.
Publicado: (2017)

Silencing of microRNA-101 prevents IL-1β-induced extracellular matrix degradation in chondrocytes
por: Dai, Linghui, et al.
Publicado: (2012)

AKT/GSK3β Signaling in Glioblastoma
por: Majewska, Ewelina, et al.
Publicado: (2016)

Autotaxin is a novel target of microRNA‐101‐3p
por: Wang, Yuqin, et al.
Publicado: (2019)

MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway
por: Zhang, Xiaohui, et al.
Publicado: (2016)

MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
por: Vella, Serena, et al.
Publicado: (2015)

Drug Nanorod-Mediated Intracellular Delivery of microRNA-101 for Self-sensitization via Autophagy Inhibition
por: Xin, Xiaofei, et al.
Publicado: (2019)

MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS
por: Long, Yongqi, et al.
Publicado: (2022)

miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP-α in glioblastoma
por: Yang, Yun-Na, et al.
Publicado: (2018)

MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma
por: Murata, Masaki, et al.
Publicado: (2023)

MicroRNA-300 inhibited glioblastoma progression through ROCK1
por: Zhou, Fucheng, et al.
Publicado: (2016)

Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression
por: Lozada-Delgado, Eunice L., et al.
Publicado: (2018)

Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
por: Zhao, Kai, et al.
Publicado: (2021)

FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells
por: Lin, Jing, et al.
Publicado: (2018)

Correlation of MicroRNA-16, MicroRNA-21 and MicroRNA-101 Expression with Cyclooxygenase-2 Expression and Angiogenic Factors in Cirrhotic and Noncirrhotic Human Hepatocellular Carcinoma
por: Zeng, Wenjiao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u317ri278m6nldmngll900n385